PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26519986-9	2016	Inhibitors (PD98059, mevastatin and genistein) of specific sites along the Ras/Raf/MEK/ERK signaling pathway, blocked the phosphorylation and concomitantly inhibited 5alphaP-induced stimulation of cell proliferation and detachment.	mevastatin	21-31	mitogen-activated protein kinase 1	Homo sapiens	87-90	
15786722-0	2005	Mevastatin induces apoptosis in HL60 cells dependently on decrease in phosphorylated ERK.	mevastatin	0-10	mitogen-activated protein kinase 1	Homo sapiens	85-88	
15786722-7	2005	When we examined the survival signals at the time of apoptotic induction, we also observed that the administration of mevastatin had caused a remarkable decrease in the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2).	mevastatin	118-128	mitogen-activated protein kinase 1	Homo sapiens	188-229	
15786722-11	2005	These results suggested that mevastatin induced apoptosis when it inhibited GGPP biosynthesis and consequently decreased the level of phosphorylated ERK, which was a survival signal; moreover, at that time, there was no influence on NF-kappaB, Akt, p38, and Bcl-2.	mevastatin	29-39	mitogen-activated protein kinase 1	Homo sapiens	149-152	
15786722-11	2005	These results suggested that mevastatin induced apoptosis when it inhibited GGPP biosynthesis and consequently decreased the level of phosphorylated ERK, which was a survival signal; moreover, at that time, there was no influence on NF-kappaB, Akt, p38, and Bcl-2.	mevastatin	29-39	mitogen-activated protein kinase 1	Homo sapiens	249-252